D
efining the regulation of embryonic stem (ES) cell-derived endoderm will contribute to our understanding of the development and function of the thyroid gland that is derived from such cells. We have shown previously that TSH-directed thyroid cell differentiation from ES cells could be observed after the formation of embryoid bodies (EBs), and as evidenced by the expression of TSH receptors (TSHRs) and the sodium iodide symporter (NIS) (1, 2) . However, we have also reported that TSHR-knockout (KO) mice, which are resistant to TSH, continue to develop thyroid glands although their thyroid cells function poorly (3) . Therefore, a factor(s) other than TSH is the major driving force for thyroid development. Early development of the thyroid gland is known to be transcriptionally regulated in vivo. Transcription factors known to be important include Nkax2.1 (TTF-1), Fox21 (TTF-2), hHex, and Pax-8, and deletion of one of these genes results in severe dysgenesis of the gland (4, 5) . However, the factors controlling such transcriptional regulation are not well defined in vivo or in vitro, although it has been suggested that local factors from adjacent cells may be important, which would also explain the association between thyroid and cardiac abnormalities (6) .
One of the known major influences on transformation to endodermal cells has recently been shown to be activin A, a ligand that activates the nodal signaling pathway (7) . It was reported that early differentiating murine ES cells could be enriched for definitive endoderm by only a short treatment with high concentrations of activin. This was consistent with findings in the gastrulating mouse embryo, which showed that high levels of nodal signaling were important for directing endoderm commitment of cells migrating through the anterior primitive streak (7, 8) .
In the present study, originally based on the work of Keller (9), we set out to identify the induction signal(s) for differentiation of ES cells into thyroid-specific endodermal stem cells. We studied the role of TSH, IGF-I, and activin A in induction and maintenance of the endodermal state, and in the induction of thyroid-specific differentiation markers. The epithelial cells that were derived by this method had a gene expression profile resembling that of thyroid-committed progenitor cells.
Materials and Methods

Growth and differentiation of ES cells
The development of the TSHR ϩ/Ϫ ES cell line has been previously reported (3) . In brief, a targeting vector carrying a green fluorescence protein (GFP)-neo' cassette was introduced into position 1 of the mouse TSHR exon 1 coding sequence, and was then linearized and electroporated into wild-type W9.5 ES cells. Subsequently, independent clones, heterozygous and homozygous, for the TSHR mutation were selected and confirmed (3) .
ES cells were routinely maintained as adherent cells on gelatin-coated dishes in DMEM (Invitrogen Life Technologies, Inc., Grand Island, NY) containing 4.5 g/liter L-D-glucose, supplemented with 10% fetal calf serum (catalog no. 06952; StemCell Technologies, Inc., Vancouver, Canada), penicillin-streptomycin (100 U/ml; Invitrogen Life Technologies), 1.5 ϫ 10 Ϫ4 M monothioglycerol (Sigma-Aldrich Corp., St. Louis, MO), and 10 ng/ml leukemia inhibitory factor (StemCell Technologies), and were cultured in a humidified chamber in a 5% CO 2 -air mixture at 37 C. Routine sterility checks, including screening for Mycoplasma, indicated that the cells were clear of contamination throughout the studies. ES cell cultures were passaged at 1:3-5 ratios every 2 d.
To induce formation of EBs, ES cells were dissociated with trypsin and transferred to plastic nontissue culture-grade petri dishes to allow their aggregation and prevent adherence to the plate. Cells were seeded at 1 ϫ 10 6 cells per petri dish. EBs were cultured overnight in the same culture medium as ES cells, except that it lacked leukemia inhibitory factor. The following day, EBs were harvested and allowed to settle by gravity in a 50-ml tube and transferred to new dishes and cultured in fresh medium supplemented with 50 ng/ml human activin A (R&D Systems, Inc., Minneapolis, MN).
To detect the possible effects of TSH and IGF-I on the differentiation of ES cells into thyroid cells, EBs were transferred on d 5 to differentiation medium that contained DMEM supplemented with penicillin/streptomycin, 15% KnockOut serum replacement medium (Invitrogen Life Technologies), 5% protein-free hybridoma medium (PFHM-II; Invitrogen Life Technologies), 0.5 mM ascorbic acid (Sigma-Aldrich), transferrin (200 g/ml; Roche, Ridgefield, CT), and 1.5 ϫ 10 Ϫ4 M monothioglycerol. The EBs were cultured in medium containing one of the following compounds: 100 U/ml human recombinant TSH (Fitzgerald Industries, Concord, MA); and/or 50 ng/ml recombinant murine IGF-I (Sigma-Aldrich). The EBs was transferred to gelatin-coated dishes on d 9, which may better support longer term culture. Cells were harvested for expression analysis at d 5, 9, and 21 (total time) culture.
Fluorescence-activated cell sorter (FACS) analysis
For FACS analysis and cell sorting, EBs were trypsinized and harvested. The resulting single-cell suspension was either analyzed on a FACSCalibur flow cytometer (BD Biosciences, Mountain View, CA) or subjected to MoFlo cell sorting (DakoCytomation, Carpinteria, CA). FACS data were analyzed on CellQuest software (BD Biosciences). Cells were analyzed for TSHR by GFP expression as described previously and for NIS expression using an anti-NIS (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) with phycoerythrin (PE)-labeled antigoat IgG as a second antibody. Both TSHR and NIS mRNA were also detected by RT-PCR analysis as described in Results.
Gene expression analysis
RNA isolation
Total RNA was isolated from the cells using the TRIZOL reagent (Invitrogen Corp., Carlsbad, CA), and chromosomal DNA was removed in accordance with the manufacturer's instructions. The RNA concentration was determined on the basis of absorbance at 260 nm, and its purity was evaluated by the ratio of absorbance at 260:280 nm (Ͼ1.9). RNAs were kept frozen at Ϫ70 C until analyzed. After digestion of genomic DNA by treatment with Ambion's TURBO DNA-free deoxyribonuclease I (Ambion, Inc., Austin, TX), total RNA (1 g) was reverse transcribed into cDNA with random hexamers using Advantage RTfor-PCR kit (CLONTECH Laboratories, Inc., Mountain View, CA).
Semiquantitative PCR
RT-PCRs were performed with TITANIUM Taq polymerase (CLONTECH Laboratories). Cycling conditions were as follows: 94 C for 1 min, followed by 30 -40 cycles of amplification (94 C denaturation for 0.5 min; annealing for 1 min, annealing temperature dependent on primers; 72 C elongation for 2 min); with a final incubation at 72 C for 7 min. The amplified PCR products were separated on 2% agarose gels and visualized by ethidium bromide staining. Details of primer sequences, annealing temperature, and cycle numbers for each PCR are shown in Table 1 .
Quantitative RT-PCRs (qRT-PCRs)
The qRT-PCRs were performed using the Applied Biosystems StepOnePlus Real-time PCR system (Applied Biosystems, Foster City, CA). The reactions were established with 10 l SYBR Green master mix (Applied Biosystems), 0.4 l (2 M) sense/antisense gene-specific primers, 2 l cDNA, and diethylpyrocarbonate-treated water to a final volume of 20 l. The PCR mix was denatured at 95 C for 60 sec before the first PCR cycle. The thermal cycle profile was: denaturizing for 30 sec at 95 C; annealing for 30 sec at 57-60 C (dependent on primers); and extension for 60 sec at 72 C. A total of 40 PCR cycles were used. PCR efficiency, uniformity, and linear dynamic range of each qRT-PCR assay were assessed by the construction of standard curves using DNA standards. An average threshold cycle from triple assays was used for further calculation. For each target gene, the relative gene expression was normalized to that of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene using Applied Biosystems StepOnePlus Real-time PCR systems software. Data presented (mean) are from three independent experiments in which all sample sets were analyzed in triplicate.
TSHR functional assessment
Intracellular cAMP generation was measured with a cAMP enzyme immunoassay kit, using novel lysis reagents (GE Healthcare Bio-Sciences Corp., Piscataway, NJ). Briefly, ES cells were seeded in a petri dish at a density of approximately 1.0 ϫ 10 5 cells per dish in 2 ml medium to form EBs in the first 24 h, and the formed EBs were treated with Activin A for 5 d. The cells were then stimulated with increasing concentration of TSH for 1 h. 8-bromo cAMP (0.2 M), a membrane-permeable analog of cAMP, was used as a positive control and SQ22536 (30 M), an adenyl cyclase inhibitor, as a negative control. The medium was then aspirated, the cells were washed with fresh PBS, then excessive PBS was aspirated completely and lysis reagent added. The plate was shaken on a microtiter plate shaker for 10 min. A total of 100 l of each sample was transferred into the appropriate well of an immunoassay microtiter plate. An incubation time of 15 min was chosen based on a time-course measurement of intracellular cAMP levels after TSH stimulation. cAMP was measured as described by the manufacturer using a nonacetylation protocol (Amersham Pharmacia Biotech, Uppsala, Sweden).
Results
The characteristics of the ES cell line
The TSHR ϩ/Ϫ ES cell line had the same stem cell gene expression repertoire as TSHR ϩ/ϩ cells (1). GFP expression, reflecting TSHR expression in the TSHR ϩ/Ϫ ES cell line, was analyzed by flow cytometry before and after in vitro differentiation of the TSHR ϩ/Ϫ ES cells into EBs, as previously reported by our laboratory (1). Figure 1A illustrates TSHR expression in these ES cells in continuous culture where less than 0.5% of cells were GFP positive. However, after 5 d differentiation (Fig. 1B) into EBs, there were up to 13% of GFP-positive cells, but only 0.5% of cells were NIS positive. When we sorted the cell cultures for GFP-positive cells by FACS, we obtained over 90% GFP-positive cells, which we then allowed to reform into EBs. This procedure produced clusters of almost entirely green EBs (Fig. 1C) .
Activin A induces endodermal cells
We found that adding activin A to cultures of EB cells markedly decreased the stem cell markers (Oct-4 and Rex-1) by d 5 compared with control EB cells ( Fig. 2A) . In contrast, when we analyzed endodermal markers, such as Gata-4, CXCR-4, Foxa-2, and ␣-fetoprotein (AFP), we observed a marked increase in the expression of these genes after 5 d exposure to activin A, in keeping with endodermal transformation of the EB cells. However, the addition of TSH and IGF-I to the activin-activated EB cultures had no influence on this differentiation process as assessed by the same marker set (Fig. 2A) . These data indicated that activin A exposure induced endodermal transformation of TSHR ϩ/Ϫ EB cells under these chemically defined experimental conditions. Furthermore, there was a marked difference in the degree of change in transcription factor expression, with a 50% decrease in stemness, yet a 10-to 70-fold increase in endodermal identification ( Fig. 2A) . By d 5, Oct4 had decreased by 31.3%, and Rex1 by 63.2%. In contrast, GATA4 had increased by 75.0%, Cxcr4 by 70.1%, Foxa2 by 52.3%, and AFP by 80.3%.
Induction of thyroid gene expression
Having established the capacity of activin A to induce endodermal transformation, we studied changes in thyroid marker expression by activin A-treated cells. Low-level expression of the thyroid nonspecific factor, Pax-8, was observed from d 1 of the culture and was independent of activin A (Fig. 2B) . However, by d 21 Pax-8 expression was markedly increased. In contrast, the NIS showed a marked increase in early gene expression by d 5 driven by activin A but was not expressed until d 21 in the absence of activin A (Fig. 2B) . TSHR gene expression also showed an increase by d 5 with activin A, and this became markedly accelerated by d 21. However, TSHR gene expression appeared to be less with the addition of TSH or IGF-I in combination with activin A rather than increased (Fig. 2C) . Furthermore, we did not observe any thyroglobulin (Tg) mRNA expression in these activin A-induced endodermal EB cells up to d 21 of the culture (Fig. 2B ).
NIS and TSHR protein expression in activin A-treated EB cells
After 5 d activin exposure, NIS protein expression was detected using flow cytometry and demonstrated a large induction of the cells positive for NIS (ϳ17%), as indicated by the PE staining with specific anti-NIS (Fig. 3A) . Although less cells (3-5%) were GFP positive indicative of TSHR expression (Fig. 3A) , we found that approximately 2% double-positive cells were also induced. Sorting for these double-positive cells allowed the confirmation of the simultaneous presence of a third marker, PAX-8 mRNA, confirming the presence of unique thyroid cell precursors (Fig. 3B) . These results demonstrated that activin A promoted the differentiation of thyroid-specific progenitor cells.
Confirmation of TSHR function in thyroid cell precursors
Five-day activin-treated EB cells were functionally analyzed by measurement of TSH stimulated cAMP generation, as shown in Fig. 4 . A dose-dependent cAMP response to TSH was observed with activin-induced cells, with a 50% maximum stimulation with 500 U/ml when compared with the lack of response with nonactivin A-treated control EB cells. The treated EB cell response to TSH had a similar pattern to that of the rat thyroid cell line (FRTL-5), showing a 50% maximum stimulation with 100 U/ml. The reduced sensitivity may be secondary to either an affinity difference in such embryonic cells or secondary to the mouse TSHR having a lower affinity for TSH than the rat. However, this analysis demonstrated that the population of activin A-induced endodermal cells had fully functional TSHRs.
Discussion
We have previously defined the TSH-induced development of "thyroid-like" progenitor cells from ES cells in vitro (1, 2) . These studies were based on the role of the major thyroid gland activator, TSH, in enticing the differentiation of such cells, and we observed the induction of TSHR expression under TSH stimulation. However, TSHR expression is not confined to thyroid cells. Functional TSHRs have been well demonstrated in adipocytes, fibroblasts, and bone cells (10 -14) , and have been demonstrated in many other cell types (14, 15) . Therefore, TSHR expression cannot be the sole marker of a thyroid progenitor cell. However, we were also able to observe, in a small number of cells, the simultaneous expression of the NIS. Although NIS expression is also found in a variety of cell types (in the mammary glands, salivary glands, and stomach) (16), the presence of both the TSHR and NIS in the same cell population was highly suggestive of the presence of thyroid progenitor cells.
However, there are a great deal of data indicating that thyroid cell development may occur in the absence of TSH, including our own early studies demonstrating neofollicle formation and continuing secretion of Tg, even in the absence of TSH (17) . Such information was evidence that TSH is not the major instigator of thyroid development, and the work of Di Lauro and colleagues (18) has amply demonstrated this with evidence that the transcription factors Nkax2.1 (TTF-1), Fox21 (TTF-2), and Pax-8, and additional genes such as hHex, are all involved (4, 5) . These observations were further exemplified by our development of the TSHR-KO mouse, which demonstrated that in the total absence of TSHR signaling, the animals still developed thyroid glands (3). The glands were located in the correct anatomical position but were reduced in size and with a marked reduction in thyroid follicle formation, although Tg formation persisted. Expression of NIS and thyroid peroxidase (TPO) was absent in the TSHR-KO mouse thyroid, and the animals were hypothyroid. Therefore, it is clear that many factors other than TSH are important in the initiation and control of thyroid gland formation.
To begin to apply this knowledge to the in vitro recapitulation of thyroid cell development, we have continued to examine our original ES cell model but with more insight. For example, we know that critical levels of Oct-4 and REX-1 expression are required to sustain stem cell self-renewal and pluripotency. Our observation that differentiation of the ES cells into EBs resulted in the appropriate down-regulation of Oct-4 and REX-1 was entirely consistent with the development of a new population of cells. The fact that thyroid follicular cells occur from the endoderm during vertebrate development made it likely that thyroid cells may be differentiated from ES cells by activin A. Activin is a member of the TGF␤ superfamily, which has been previously shown to be critical in regulating endoderm formation in vitro (7, 19) and in vivo (20) , and acts as a substitute for nodal (7, 9) . To define the potential of activin A induction of thyroid endoderm, we first examined the expression of a selection of endodermal markers in EB cells treated with activin A for 5 d. GATA-4, one of a family of transcription factors that are implicated in early cell maturation and embryonic development, and AFP, an endodermal-specific marker, increased as the ES cells were exposed to activin A, confirming the expected endodermal transformation.
We then proceeded to examine thyroid gene expression to determine the induction of thyroid progenitor cells in the absence of TSH. We found that we not only induced the TSHR but that there was a marked induction of NIS-expressing cells. The simultaneous presence of both the TSHR and NIS in the same cell population was confirmed in double-marker sorting studies, and the detection of Pax-8 expression confirmed that we were once again dealing with the induction of a small number of true thyroid progenitor cells. Such cells now need to be cultured and characterized.
To date we have not been able to consistently detect Tg gene expression or TPO gene expression (data not shown) in ES cell cultures. In particular, the low Tg and TPO expression levels in our earlier experiments (2) may have related to specificity of the PCR studies and were not seen subsequently (1) . It appears that the Tg and TPO genes are transcriptionally inactive, or at least quiet, in these cells, and, therefore, the possibility of full functionality is absent. There are a variety of known transcriptional inhibitors of Tg gene expression, such as DREAM and HEX, and studies of these factors may reveal the reasons for this gene silencing, even in cells expressing Pax-8, the TSHR, and NIS (4, 5) .
In summary, we have succeeded in recapitulating the development of thyroid endodermal progenitor cells in vitro using EB transformation and a chemically defined differentiation protocol that resulted in a small population of cells expressing Pax-8, the TSHR, and NIS. The surprising absence of Tg transcriptional activity suggests that factors present within such progenitor cells Both NIS protein expression (as PE, the vertical axis) and TSHR expression (as GFP, the horizontal axis) were detected in these activin A-treated EB cells. As indicated in the right panel, we observed approximately 2% of the cells to be double positive for NIS and TSHR after exposure to activin A. B, The double-positive cells seen in 3A were subjected to RT-PCR for Pax-8, TSHR, and NIS. All three were found to be present. Unexposed EB cells served as negative controls, and rat (FRTL-5) thyroid cells served as positive controls.
provide transcriptional inhibition of the Tg gene, and their identification and regulation are necessary to proceed to procuring fully functional thyroid cells.
